Latest news with #CatapultGroupInternational
Business Insider
5 hours ago
- Business
- Business Insider
Catapult Group International (CAZGF) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst Owen Humphries maintained a Buy rating on Catapult Group International (CAZGF – Research Report) on June 6 and set a price target of A$6.20. The company's shares closed last Thursday at $4.15. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Humphries is a 4-star analyst with an average return of 8.4% and a 42.44% success rate. Humphries covers the Technology sector, focusing on stocks such as Catapult Group International, Gentrack Group Ltd, and Smart Parking Limited. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Catapult Group International with a $3.53 average price target, which is a -14.94% downside from current levels. In a report released on May 30, Morgan Stanley also maintained a Buy rating on the stock with a A$6.00 price target.
Business Insider
30-05-2025
- Business
- Business Insider
Catapult Group International (CAZGF) Gets a Buy from Morgan Stanley
In a report released today, Andrew McLeod from Morgan Stanley maintained a Buy rating on Catapult Group International (CAZGF – Research Report), with a price target of A$6.00. The company's shares closed last Wednesday at $3.34. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter McLeod covers the Communication Services sector, focusing on stocks such as News Corp, News Corporation Shs B Chess Depository Interests repr 1 Sh, and REA Group Ltd. According to TipRanks, McLeod has an average return of 2.0% and a 52.00% success rate on recommended stocks. Catapult Group International has an analyst consensus of Strong Buy, with a price target consensus of $3.26, which is a -2.25% downside from current levels. In a report released on May 22, Canaccord Genuity also maintained a Buy rating on the stock with a A$5.00 price target. The company has a one-year high of $3.49 and a one-year low of $1.01. Currently, Catapult Group International has an average volume of 3,440.
Business Insider
26-05-2025
- Business
- Business Insider
Canaccord Genuity Keeps Their Buy Rating on Catapult Group International (CAZGF)
Canaccord Genuity analyst Owen Humphries maintained a Buy rating on Catapult Group International (CAZGF – Research Report) on May 22 and set a price target of A$5.00. The company's shares closed last Thursday at $2.97. Confident Investing Starts Here: According to TipRanks, Humphries is ranked #2028 out of 9536 analysts. In addition to Canaccord Genuity, Catapult Group International also received a Buy from UBS's Evan Karatzas in a report issued on May 21. However, on the same day, Bell Potter downgraded Catapult Group International (Other OTC: CAZGF) to a Hold. The company has a one-year high of $3.14 and a one-year low of $0.95. Currently, Catapult Group International has an average volume of 3,445.
Business Insider
22-05-2025
- Business
- Business Insider
Catapult Group International (CAZGF) was downgraded to a Hold Rating at Bell Potter
Bell Potter analyst Chris Savage downgraded Catapult Group International (CAZGF – Research Report) to a Hold today and set a price target of A$5.00. The company's shares closed today at $3.14. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter According to TipRanks, Savage is a 4-star analyst with an average return of 4.6% and a 46.10% success rate. Savage covers the Technology sector, focusing on stocks such as Catapult Group International, Life360 Shs Chess Depository Interests Repr 3 Sh, and Wisetech Global. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Catapult Group International with a $2.93 average price target. The company has a one-year high of $2.89 and a one-year low of $0.93. Currently, Catapult Group International has an average volume of 3,435.
Yahoo
21-05-2025
- Business
- Yahoo
Catapult Group International And 2 Other High Growth Tech Stocks In Australia
The Australian market has shown a mix of performances recently, with the ASX 200 closing up by 0.52% and sectors like Energy and Health Care leading gains, while Industrials lagged behind. In this context of varied sector performance, identifying high growth tech stocks such as Catapult Group International requires careful consideration of their innovation potential and adaptability to current market dynamics. Name Revenue Growth Earnings Growth Growth Rating Gratifii 42.14% 113.99% ★★★★★★ Pro Medicus 22.19% 23.49% ★★★★★★ BlinkLab 65.54% 64.35% ★★★★★★ WiseTech Global 20.14% 25.01% ★★★★★★ Pointerra 50.42% 159.12% ★★★★★☆ Wrkr 57.01% 116.83% ★★★★★★ AVA Risk Group 29.15% 108.15% ★★★★★★ Immutep 70.42% 42.39% ★★★★★☆ Echo IQ 61.50% 65.86% ★★★★★★ SiteMinder 19.93% 69.52% ★★★★★☆ Click here to see the full list of 49 stocks from our ASX High Growth Tech and AI Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Catapult Group International Ltd is a sports science and analytics company that offers technologies to enhance athlete performance, prevent injuries, and facilitate recovery for sporting teams across multiple regions including Australia, Europe, the Middle East, Africa, the Asia Pacific, and the Americas; it has a market cap of A$1.29 billion. Operations: Catapult Group International Ltd specializes in providing innovative technologies to sporting teams and athletes for optimizing performance and injury prevention. The company operates across various regions, leveraging its expertise in sports science and analytics to support athlete recovery and return-to-play strategies. Catapult Group International Ltd has demonstrated a robust trajectory with its annual revenue surging by 16.53% to USD 116.53 million, alongside reducing its net loss significantly from USD 16.7 million to USD 8.81 million in the latest fiscal year. The launch of Vector 8 marks a pivotal advancement in sports technology, offering real-time performance analytics and operational efficiencies that could revolutionize athlete management across various sports by integrating advanced sensors and AI-driven data analysis into its platform. This innovation aligns with Catapult's inclusion in the S&P/ASX Small Ordinaries Index, reflecting growing investor confidence amidst forecasts of revenue growth at an annual rate of 13.9% and becoming profitable within three years—a pace set to outstrip broader market expectations. Get an in-depth perspective on Catapult Group International's performance by reading our health report here. Understand Catapult Group International's track record by examining our Past report. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market capitalization of approximately A$823.53 million. Operations: Nuix Limited generates revenue primarily from its Software & Programming segment, which amounted to A$227.37 million. The company's business model focuses on providing software solutions for investigative analytics and intelligence across multiple global regions. Nuix, recently added to the S&P/ASX 200 Index, is navigating a challenging phase with a reported increase in sales to AUD 105.19 million from AUD 98.44 million year-over-year, yet experiencing a widening net loss from AUD 4.83 million to AUD 10.4 million in the latest half-year results. Despite current unprofitability, Nuix's revenue growth is projected at an impressive annual rate of 15.3%, outpacing the Australian market average of 5.5%. This growth trajectory is supported by strategic R&D investments aimed at enhancing their software solutions, positioning Nuix to potentially turn profitable within the next three years as forecasted by industry analysts who expect earnings to surge by approximately 54% annually. Delve into the full analysis health report here for a deeper understanding of Nuix. Gain insights into Nuix's historical performance by reviewing our past performance report. Simply Wall St Growth Rating: ★★★★★☆ Overview: Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company that develops and commercializes therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases across Australia, Belgium, Japan, Switzerland, and the United States with a market cap of A$8.68 billion. Operations: The company generates revenue primarily from Precision Medicine (A$771.11 million), followed by Therapeutics (A$9.35 million) and Manufacturing Solutions (A$2.75 million). Telix Pharmaceuticals, a frontrunner in the high-growth sector of radiopharmaceuticals, is making significant strides in expanding its global footprint. Recently securing marketing authorization for Illuccix® in multiple European countries, Telix is enhancing prostate cancer diagnosis with its advanced PSMA-PET imaging technology. This expansion follows a robust 19.5% annual revenue growth and an impressive 33.2% forecast in earnings growth, underpinned by strategic R&D investments which totaled $50 million last year—approximately 12% of their total revenue. These developments not only underscore Telix's commitment to innovation but also position it well for sustained growth in the dynamic field of medical diagnostics and treatment solutions. Click here to discover the nuances of Telix Pharmaceuticals with our detailed analytical health report. Learn about Telix Pharmaceuticals' historical performance. Navigate through the entire inventory of 49 ASX High Growth Tech and AI Stocks here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CAT ASX:NXL and ASX:TLX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
